Leishmania major and HIV co-infection in Burkina Faso

References 

1. Alvar J. Leishmaniasis and AIDS co-infection: the Spanish example. Parasitology Today. 1994;10:160–163
2. Bories PN, Le Moel G, Devanlay M, Bories C, Damasio M, Leluan G. Beta 2-microglobulin in liver cirrhosis: study of a local synthesis in ascitic fluid. Biomedical Pharmacotherapy. 1987;41:44–47
3. Desieux P. The increase in risk factors for leishmaniasis worldwide. Transactions of the Royal Society of Tropical Medicine and Hygiene. 2001;95:239–243
   • Abstract
   • Full-Text PDF (10205 KB)
   • CrossRef
4. Kubar J, Marty P, Lelievre A, Quaranta JF, Staccini P, Caroli-Bosc C, et al. Visceral leishmaniasis in HIV-positive patients: primary infection, reactivation and latent infection. Impact of the CD4+ Tlymphocyte counts. AIDS. 1998;12:2147–2153
   • MEDLINE
   • CrossRef
5. Marty P, Lelievre A, Quaranta JF, Rahal A, Gari-Toussaint M, Le Fichoux Y. Use of the leishmanin skin test and western blot analysis for epidemiological studies in visceral leishmaniasis areas: experience in a highly endemic focus in Alpes-Maritimes (France). Transactions of the Royal Society of Tropical Medicine and Hygiene. 1994;88:658–659
   • Abstract
   • Full-Text PDF (243 KB)
   • CrossRef
6. Traore KS, Sawadogo NO, Traore A, Ouedraogo JB, Traore KL, Guiguemde TR. Preliminary study of cutaneous leishmaniasis in the town of Ouagadougou from 1996 to 1998. Bulletin de la Societe de Pathologie Exotique. 2001;94:52–55
7. UNAIDS . AIDS Epidemic Update. Geneva: UNAIDS; 1998;